BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 26299738)

  • 21. Utility of circulating tumor DNA in cancer diagnostics with emphasis on early detection.
    Fiala C; Diamandis EP
    BMC Med; 2018 Oct; 16(1):166. PubMed ID: 30285732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell-free DNA detected by "liquid biopsy" as a potential prognostic biomarker in early breast cancer.
    Maltoni R; Casadio V; Ravaioli S; Foca F; Tumedei MM; Salvi S; Martignano F; Calistri D; Rocca A; Schirone A; Amadori D; Bravaccini S
    Oncotarget; 2017 Mar; 8(10):16642-16649. PubMed ID: 28186965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating cell-free nucleic acids: characteristics and applications.
    Pös O; Biró O; Szemes T; Nagy B
    Eur J Hum Genet; 2018 Jul; 26(7):937-945. PubMed ID: 29681621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of DNA Integrity, Applications for Cancer Research.
    Zonta E; Nizard P; Taly V
    Adv Clin Chem; 2015; 70():197-246. PubMed ID: 26231488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of commercial kits for purification of circulating free DNA.
    Diefenbach RJ; Lee JH; Kefford RF; Rizos H
    Cancer Genet; 2018 Dec; 228-229():21-27. PubMed ID: 30553469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating Tumor Cells and Circulating Tumor DNA: Challenges and Opportunities on the Path to Clinical Utility.
    Ignatiadis M; Lee M; Jeffrey SS
    Clin Cancer Res; 2015 Nov; 21(21):4786-800. PubMed ID: 26527805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor-specific methylations in circulating cell-free DNA as clinically applicable markers with potential to substitute mutational analyses.
    Andersen RF
    Expert Rev Mol Diagn; 2018 Dec; 18(12):1011-1019. PubMed ID: 30411633
    [No Abstract]   [Full Text] [Related]  

  • 28. Circulating DNA: a new diagnostic gold mine?
    Ziegler A; Zangemeister-Wittke U; Stahel RA
    Cancer Treat Rev; 2002 Oct; 28(5):255-71. PubMed ID: 12435372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential of circulating tumor cells as blood-based biomarkers in cancer liquid biopsy.
    Schlange T; Pantel K
    Pharmacogenomics; 2016 Feb; 17(3):183-6. PubMed ID: 26799583
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical utility of emerging liquid biomarkers in advanced prostate cancer.
    Vandekerkhove G; Chi KN; Wyatt AW
    Cancer Genet; 2018 Dec; 228-229():151-158. PubMed ID: 28958406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The potential of circulating nucleic acids as components of companion diagnostics for predicting and monitoring chemotherapy response.
    Schwarzenbach H
    Expert Rev Mol Diagn; 2015 Feb; 15(2):267-75. PubMed ID: 25382372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantification of circulating cell-free DNA in the plasma of cancer patients during radiation therapy.
    Cheng C; Omura-Minamisawa M; Kang Y; Hara T; Koike I; Inoue T
    Cancer Sci; 2009 Feb; 100(2):303-9. PubMed ID: 19200259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Applications of DNA-Based Liquid Biopsy for Central Nervous System Neoplasms.
    Wang J; Bettegowda C
    J Mol Diagn; 2017 Jan; 19(1):24-34. PubMed ID: 27863260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The feasibility of using mutation detection in ctDNA to assess tumor dynamics.
    Yi X; Ma J; Guan Y; Chen R; Yang L; Xia X
    Int J Cancer; 2017 Jun; 140(12):2642-2647. PubMed ID: 28124376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating nucleic acids as a tumor marker.
    Chan KC; Lo YM
    Histol Histopathol; 2002; 17(3):937-43. PubMed ID: 12168805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of cell free DNA in breast oncology.
    Canzoniero JV; Park BH
    Biochim Biophys Acta; 2016 Apr; 1865(2):266-74. PubMed ID: 27012505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell-free circulating tumor DNA in cancer.
    Qin Z; Ljubimov VA; Zhou C; Tong Y; Liang J
    Chin J Cancer; 2016 Apr; 35():36. PubMed ID: 27056366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating tumour DNA (ctDNA) as a liquid biopsy for melanoma.
    Calapre L; Warburton L; Millward M; Ziman M; Gray ES
    Cancer Lett; 2017 Sep; 404():62-69. PubMed ID: 28687355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Future perspectives of circulating tumor DNA in colorectal cancer.
    Nadal C; Winder T; Gerger A; Tougeron D
    Tumour Biol; 2017 May; 39(5):1010428317705749. PubMed ID: 28488528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advances in Circulating Tumor DNA Analysis.
    Perakis S; Auer M; Belic J; Heitzer E
    Adv Clin Chem; 2017; 80():73-153. PubMed ID: 28431643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.